OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Result of AGM
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, announces that all resolutions were duly passed at the Annual General Meeting held earlier today.
The results are set out below:
Resolution |
For |
Against |
Discretion to Chairman |
Withheld |
Total |
1 |
9,374,684 |
23,021 |
32,985 |
88,420 |
9,519,110 |
2 |
9,421,626 |
59,735 |
32,985 |
4,764 |
9,519,110 |
3 |
5,015,063 |
4,138,825 |
32,985 |
332,237 |
9,519,110 |
4 |
5,095,359 |
358,971 |
32,985 |
4,031,795 |
9,519,110 |
5 |
8,514,388 |
963,219 |
32,985 |
8,518 |
9,519,110 |
6 |
8,430,095 |
1,047,954 |
32,985 |
8,076 |
9,519,110 |
Contacts:
Omega Diagnostics Group PLC |
|
Colin King, Chief Executive |
via Walbrook PR |
Chris Lea, Chief Financial Officer |
|
|
|
finnCap Ltd |
Tel: 020 7220 0500 |
Geoff Nash/Edward Whiley (Corporate Finance) |
|
Alice Lane/ Charlotte Sutcliffe (ECM) |
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus |
Mob: 07980 541 893 |
Lianne Cawthorne |
Mob: 07584 391 303 |